5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide

Base Information

• Chemical Name: 5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide
• CAS No.: 1944-12-3
• Molecular Formula: C17H22BrNO4
• Molecular Weight: 384.31
• Hs Code.: 29225090
• Mol file: 1944-12-3.mol

Synonyms:Partusisten;5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide;[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]-[1-(4-hydroxyphenyl)propan-2-yl]azanium;bromide;TH 1165A;EINECS 217-742-8;1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-, HBr;1-(3,5-Dihydroxy-phenyl)-2-((1-(4-hydroxybenzyl)ethyl)amino)-ethanol hydrobromide;Benzyl alcohol, 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-, hydrobromide;LS-42859

Chemical Property of 5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide

Chemical Property:

• Vapor Pressure: 1.19E-13mmHg at 25°C
• Melting Point: 226-228 ºC
• Boiling Point: 566 °C at 760 mmHg
• Flash Point: 203.1 °C
• PSA: 92.95000
• LogP: 3.40660
• Storage Temp.: Refrigerator
• Solubility.: Soluble in water and in ethanol (96 per cent).
• Hydrogen Bond Donor Count: 5
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 6
• Exact Mass: 383.07322
• Heavy Atom Count: 23
• Complexity: 310

Purity/Quality:

99%, ^*data from raw suppliers

Fenoterol Hydrobromide ^*data from reagent suppliers

Safty Information:

• Pictogram(s): Xn
• Hazard Codes: Xn
• Statements: 22
• Safety Statements: 36

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC(CC1=CC=C(C=C1)O)[NH2+]CC(C2=CC(=CC(=C2)O)O)O.[Br-]
• Recent EU Clinical Trials: External Cephalic Version with uterine relaxation: atosiban versus fenoterol, a multi-centre trial
• Uses: An β2-adrenergic agonist. Bronchodilator; tocolytic.
• Therapeutic Function: Bronchodilator
• Clinical Use: Fenoterol is an investigational drug in the United States that has been in use in Europe since 1970. It is the p-hydroxyphenyl derivative of metaproteronol, and the combination of the resorcinol ring and the bulky p-hydroxyphenyl isopropyl group on the nitrogen gives fenoterol significant β2-receptor selectivity. It has approximately half the affinity for the β2-receptor as compared to albuterol. The resorcinol ring is resistant to COMT metabolism, and the bulky nitrogen substituent greatly retards MOA metabolism as well giving fenoterol a reasonable oral bioavailability with pharmacokinetics similar to albuterol (i.e., rapid onset and a 4- to 6-hour duration of action after oral inhalation).